Vertex's inaxaplin shows positive phase 2b data in kidney disease
New midstage results for Vertex's inaxaplin could expand its reach beyond the patient group targeted in the pivotal trial.
Clinical AI, drug discovery, devices, and regulatory approvals.
New midstage results for Vertex's inaxaplin could expand its reach beyond the patient group targeted in the pivotal trial.
A suspected measles outbreak in Bangladesh underscores the danger of slipping childhood vaccination rates.
After years of stagnation, treatment for HER2-positive gastroesophageal adenocarcinoma has advanced quickly, with successive new standards of care emerging in the past five years.
A new mouse model that reproduces a rare genetic encephalopathy associated with the DHDDS gene gives researchers a tool to study how the disease develops.
New data show barzolvolimab may be the most effective treatment yet for chronic hives, but two life-threatening allergic reactions overshadow the results and raise regulatory hurdles.
Researchers have identified immune cells that may explain why the autoimmune attack in type 1 diabetes persists for years.
MedPage Today's roundup highlights two cardiologists appointed to the U.S. Preventive Services Task Force, alongside briefs on an atrial fibrillation device and a tree-related injury.
A new study finds that the prognostic significance of a pacemaker after transcatheter aortic valve implantation differs by sex.
The leader of New Jersey's largest health system will step down next year, prompting a national search that is expected to conclude by early 2027.
A defense motion asks a judge to investigate the conduct of the lone juror who wanted to convict the Massachusetts mother.
A Mass General Brigham preclinical study proposes a shared explanation for delayed allergy onset and the development of multiple allergies.
A University of Gothenburg study shows basic cleaning methods can reduce bacteria on single-use medical devices, offering a potential emergency fallback during supply shortages.
Five HCA-affiliated Texas hospitals allege the BlueCard program still causes denied claims despite a $2.8B settlement.
The apparent increase in smokers' five-year death risk from 1987 to 2013 is driven by an older smoking population, not by cigarettes becoming deadlier.
An AI system that learns from radiology reports could help radiologists spot problems in complex abdominal CT scans.
The new platform combines substance use, mental health, and behavioral addiction care with AI-powered triage to route patients to appropriate treatment.
A 65-year-old's experience illustrates how inconsistent primary care can disrupt routine prescriptions for common maintenance medications.
A UK clinic reports that non-prescribed ketamine use can lead to bladder problems starting as early as age 13, according to a new clinical letter.